肝癌的细胞凋亡和治疗

摘要/Abstract

摘要： 细胞凋亡作为生物细胞对内外信号刺激的一种反应, 在正常细胞的发育过程中精确调控细胞的死亡过程, 凋亡的产生可能由不同的生理、生化或和有毒物质诱发。细胞增殖和细胞凋亡之间的平衡在器官发育及其大小维持方面起重要作用;肿瘤的发生与正常的细胞凋亡过程被抑制, 破坏了细胞增殖与凋亡之间的平衡有一定关系。用药物(如阿蒂霉素) 诱导肝癌细胞凋亡, 可达到抑制肝癌细胞分裂的效果, 治疗肿瘤。联合用药可以大大提高疗效。肝癌的基因治疗是一项新技术, 已有报道多个基因诱导肝癌细胞凋亡。

关键词: 细胞凋亡, 肝癌, 治疗

Abstract: Cell apoptosis as a response for cells to internal or external signals controls accurately the death program of cell development.Apoptosis maybe be induced by differential physiological, biochemical or poisonous materials.The balance between cell proliferation and apoptosis is essential for the development and maintenance of normal organs.The occurrence of cancers is purportedly due to the inhibition of normal apoptosis process, which caused the imbalance between cell proliferation and apoptosis.Some drugs (e.g.adriamycin, doxorubicin, propolis)can induce apoptosis, repress the division of liver cancer cells and thus treat cancers.Combination of drugs can increase the pharmacotherapeutic effect on liver cancers.The gene therapeutics to liver cancer is a new technique.It has been reported that multigenes can induce apoptosis in liver cancers.

Key words: apoptosis, liver cancer, therapeutics

中图分类号:

单长民, 李娟, 李璞. 肝癌的细胞凋亡和治疗[J]. 中国临床药理学与治疗学, 2006, 11(8): 851-856.

SHAN Chang-min, LI Juan, LI Pu. Apoptosis and therapeutic for cells of liver cancers SHAN Chang-min, LI Juan, LI Pu[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(8): 851-856.

参考文献

1 Andrikoula M, Tsatsoulis A.The role of Fas-mediated apoptosis in thyroid disease[J].Eur J Endocrinol, 2001;144:561-8
2 Thornberry NA, Lazebnik Y.Caspsase:Enemies Within[J].Science,1998;281:1312-5
3 Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, et al.Ordering the cytochrome c-initiated caspase cascade:hierarchical activation of caspases-2, -3,-6,-7, -8and-10in a caspase-9-dependent manner[J].J Cell Biol, 1999;144:281-92
4 Madesh M, Hajnoczky G.VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome C release[J].J Cell Biol , 2001;155:1003-15
5 Green DR, Reed JC.Mitochondria and Apoptosis[J].Science,1998;281:1309-15
6 Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ.Movement of Bax from the cytosol to mitochondria during apoptosis[J].J Cell Biol, 1997;139:1281-92
7 Mitry RR, Sarraf CE, Wu CG, PignatelliM, Habib NA.Wildtype p53 induces in Hep3B through up-regulation of bax expression[J].Lab Invest, 1997;77:369-78
8 Terada T, Nakanuma Y.Expression of apoptosis, proliferating cell nuclear antigen, and apoptosis-related antigen (bcl-2, c-myc,Fas, Lewis(y) and p53) in human cholangiocarcinomas and hepatocellular carcinomas[J].Pathol Int , 1996;46:764-70
9 Lee GH.Correlation between bcl-2 expression and histopathology in diethylnitrosamine-induced mouse hepatocellular tumors[J].Am J Pathol, 1997;151:957-61
10 Wang XW, Xie H.Presence of Fas and Bcl-2 proteins in BCL-7404 human hepatoma cells[J].World J Gastroenterol, 1998;4:540-3
11 Gao G, Dou QP.N-terminal cleavage of Bax by calpain generates a potent proapoptotic 18-kD fragment that promotes Bcl-2-independent cytochrome C release and apoptotic cell death[J].J Cell Biochem, 2001;80:53-72
12 Huang YL, Chou CK.Bcl-2 blocks apoptotic signal of transforming growth factor-beta in human hepatoma cells[J].J Biomed Sci, 1998;5:185-91
13 Nakay ama N, Eichhorst ST, MullerM, Krammer PH.Ethanolinduced apoptosis in hepatoma cells proceeds via intracellular Chin J Clin Pharmacol Ther 2006 Aug;11(8)Ca2 + elevation, activation of TLCK-sensitive proteases, and cytochrome c release[J].ExPCell Res, 2001;269:202-13
14 Zhang RG, Wang XW, Guo LX, Xie H.Growth inhibition of BEL-7404 human hepatoma cells by expression of mutant telomerase reverse transcriptase[J].Int J Cancer, 2002;97:173-9
15 Kanzler S, Galle PR.Apoptosis and the liver[J].Semin Cancer Biol, 2000;10:173-84
16 Bold RJ, Virudachalam S, McConkey DJ.BCL2 expression correlates with metastatic potential in pancreatic cancer cell lines[J].Cancer, 2001;92:1122-9
17 Shan CM, Li J.Study of apoptosis in human liver cancers[J].World J Gastroenterol, 2002;8:247-52
18 Bell K, Bronner MP, Pasha T, Furth EE.Expression of proliferating cell nuclear antigen in gastrointrstinaltherapeutic ct lesions and its relationshiPto bcl-2 expression[J].Pathobiology, 1996;64:91-8
19 彭晓谋, 彭文伟, 陈青, 姚集鲁.肝细胞癌P53, BCL-2 蛋白的表达和细胞凋亡[J].华人消化杂志, 1998;6:834-6
20 单长民, 刘同慎, 马云.肝胆管癌中bcl-2、bax 基因表达和细胞凋亡的研究[J].解剖学报, 2002;33:441-5
21 李娟, 单长民.肝癌中细胞凋亡相关基因的表达及其意义[J].解剖学杂志, 2002;25:479-83
22 单长民, 刘乃国, 刘同慎.人肝癌细胞基因组中HBV DNA的整合与c-fos 、p53 基因表达之间的关系[J].中国组织化学与细胞化学杂志, 2001;10:58-62
23 Kim JA, Kang YS, Jung MW, Lee SH, Lee YS.Involvement of Ca2 + influx in the mechanism of tamoxifen-induced apoptosis in HepG2 hunan hepatoblastoma cell[J].Cancer lett, 1999;147:115-23
24 Hashimoto Y, Hibasami H, Tamaki S, Kamei A, Ikoma J, Kaito M, et al.Induction of Apoptotic Cell Death In Human Hepatocellular Carcinoma SK-HEP-1 Cells By A Polyamine Synthesis Inhibitor, Methylglyoxal Bis(Cyclopentylamidinohydrazone) [J].Anticancer Drugs, 1999;10:323-7
25 Shen HM, Yang CF, Ong CN.Sodium selenite-induced oxidative stress and apoptosis in human hepatoma HepG2 cells[J].Int J Cancer, 1999;81:820-8
26 Chen X, Liu Z, Ai Z.Antineoplastic mechanism of Octreotide action in human hepatoma[J].Chin Med J , 2001;114:1167-70
27 Chen CH, Huang LL, Huang CC, Lin CC, Lee Y, Lu FJ.Baicalein,a novel apoptotic agent for hepatoma cell lines:a potential medicine for hepatoma[J].Nutr Cancer, 2000;38:287-95
28 刘军, 柳惠图, 梁云燕, 王代树.复方中药白龙对G1 期人胃癌细胞中抑癌基因的影响及与PKA 信号通路的相关性[J].中国中西医结合杂志, 1999;19;613-5
29 邓友平, 林晨, 张雪艳, 陈德权, 肖培根, 吴日文.三氧化二砷诱导人食管癌Ec109 细胞凋亡伴随c-myc 基因的降调节[J].中国医学科学院学报, 2000;22:67-70
30 刘琳, 秦叔逵, 陈惠英, 王锦鸿, 陈鸿, 马军, 等.三氧化二砷选择性诱导人肝癌细胞凋亡及相关基因的实验研究[J].中华肝脏病杂志, 2000;8:367-37
31 Lin SY, Liu JD, Chang HC, Ye SD, Lin CH, Lee WS.Magnolol suppresses proliferation of cultured human colon and liver cancer cells by inhibiting DNA synthesis and activating apoptosis[J].Journal of Cellular Biochemistry, 2002;84:532-44
32 单长民, 胡娟娟, 杜冠华.白英提取物诱导人肝癌BEL-7404 细胞凋亡作用[J].中国临床药理学与治疗学, 2001;6:200-3
33 GagandeePS, Novikoff PM, OttM,Gupta S.Paclitaxel shows cytotoxic activity in human hepatocellular carcinoma cell line[J].Cancer lett, 1999;136:109-18
34 Asakura T, Sawai T, Hashidume Y, Ohkawa S, Yokoy ama S, Ohkawa K.Caspase-3 activation during apoptosis caused by glutathione-doxorubicin conjugate[J].Br J Cancer, 1999;80:711-5
35 Hung WC, Chuang LY.Sodium butyrate enhances STAT 1 expression in PLC PRF 5 hepatoma cells and augments their responsiveness to interferon-alpha[J].Br J Cancer, 1999;80:705-10
36 Herold C, Ganslmayer M, Ocker M, Hermann M, Hahn EG,Schuppan D.Combined in vitro anti-tumoral action of tamoxifen and retinoic acid derivatives in hepatoma cells[J].Int J Oncol,2002;20:89-96
37 Sun J, Zhang J, Chen J, Chen H, Chew Y, Chen J.In vitro study on the morphology of human blood dendritic cells and LPAK cells inducing apoptosis of the hepatoma cell line[J].Chin Med J, 2001;114:600-5
38 Luo D, samuel CS, Yong X.Expression of bcl-2 family proteins during chemotherapeutic agents-induced apoptosis in the hepatoblastoma HepG2cell line[J].Br J Biomed Sci, 1999;56:114
39 Diaconu CC, SzathmariM, Keri G, Venetianer A.Apoptosis is induced in both drug-sensitive and multidrug-resistant hepatoma cells by somatostatin analogue TT-232[J].Br J Cance, 1999;80:1197-203
40 Cui YY, Xie H, Qi KB, He YM, Wang JF.Effects of Pinus massoniana bark extract on cell proliferation and apoptosis of human hepatoma BEL-7402 cells[J].World J Gastroenterol, 2005;11:5277-82
41 Jia XD, Han C, Chen JS.Tea pigments induce cell-cycle arrest and apoptosis in HepG2 cells[J].World J Gastroenterol,2005;11:5273-6
42 Park SS, Eom YW, Choi KS.Cdc2 and Cdk2 play critical roles in low dose doxorubicin-induced cell death through mitotic catastrophe but not in high dose doxorubicin-induced apoptosis[J].Biochem Biophy s Res Commun, 2005;334:1014-21
43 王征旭, 何振平, 吴祖泽, 张伟伟.腺病毒介导多基因对肝癌细胞的诱导作用[J].中华肝脏病杂志, 2000;8:224-6
44 Haberkorn U, Altmann A, Kamencic H, Morr I, Traut U,Henze M, et al.Glucose transport and apoptosis after gene therapy with HSV thymidine kinase[J].Eur J NuclMed, 2001;28:1690-6
45 Krohne TU, Shankara S, Geissler M, Roberts BL,Wands JR,Blum HE, et al.Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphory lase and thymidine kinase in human hepatocellular carcinoma cells in vitro[J].Hepatology, 2001;34:511-8

[1]	何李华, 朱秀之, 江一舟. 三阴性乳腺癌免疫治疗研究进展[J]. 中国临床药理学与治疗学, 2023, 28(8): 842-853.
[2]	张胡云龙, 朱秀之, 金希, 邵志敏. 腔面型乳腺癌内分泌治疗耐药的机制与治疗进展[J]. 中国临床药理学与治疗学, 2023, 28(8): 854-865.
[3]	付晓玉, 孔德光, 李娟娟. 三阳性乳腺癌的治疗进展[J]. 中国临床药理学与治疗学, 2023, 28(8): 866-875.
[4]	罗师萍, 张捷, 俞育帅, 宋传贵. HER2阳性乳腺癌的靶向治疗进展[J]. 中国临床药理学与治疗学, 2023, 28(8): 876-886.
[5]	向奕玫, 张宁宁, 黄雨昕, 曾晓华. HER2阳性乳腺癌疗效相关生物标志物研究进展[J]. 中国临床药理学与治疗学, 2023, 28(8): 887-897.
[6]	侯琼, 刘飞, 陈传荣. 免疫治疗联合抗血管生成药物+化疗在驱动基因阴性晚期非小细胞肺癌中的应用[J]. 中国临床药理学与治疗学, 2023, 28(7): 775-779.
[7]	王安婧, 王亚亚, 梁轩, 闫雅婕, 苏静, 李彩东. 基于PPAR治疗胆汁淤积性肝病的机制与药物研究进展[J]. 中国临床药理学与治疗学, 2023, 28(7): 796-808.
[8]	李青华, 赵艳, 赵海港, 高朋飞, 徐炳欣. ABCB1 G2677T 基因多态性检测在缺血性脑卒中患者应用阿托伐他汀降脂治疗中的价值[J]. 中国临床药理学与治疗学, 2023, 28(6): 633-640.
[9]	王娟, 刘维英, 叶育才, 付文丽, 张莎, 李乐萍. 去甲肾上腺素再摄取抑制剂联合抗毒蕈碱剂治疗阻塞性睡眠呼吸暂停的研究进展[J]. 中国临床药理学与治疗学, 2023, 28(6): 714-720.
[10]	杨晓佳, 江萌, 吴敏, 张伊黎, 吕兰, 吴嫄芬, 王鑫昱, 刘立权. 藏红花素介导DKK3调控GSK-3β/β-catenin通路对阿尔兹海默症大鼠的认知改善作用[J]. 中国临床药理学与治疗学, 2023, 28(5): 489-497.
[11]	陈满新, 张丙雨, 戴敏. 冠状动脉内靶向应用重组人尿激酶原联合经皮冠状动脉成形术治疗高负荷血栓急性心肌梗死临床疗效[J]. 中国临床药理学与治疗学, 2023, 28(5): 544-549.
[12]	张莉, 蔺兴遥, 尚芸, 王强. 冻伤的病理机制及治疗研究进展[J]. 中国临床药理学与治疗学, 2023, 28(3): 347-354.
[13]	俞亚红, 宋昱. 左心室辅助装置植入患者的药物治疗[J]. 中国临床药理学与治疗学, 2023, 28(2): 198-204.
[14]	王丹, 鄢晓丽, 张渊. 幽门螺杆菌感染影响胃癌免疫治疗的研究进展[J]. 中国临床药理学与治疗学, 2023, 28(2): 228-234.
[15]	王剑, 孙永东, 周兴玮, 刘雷, 陈龙, 童兴科, 朱佳丽. 黄芩素经由miR-125b-5p/IRF4轴进而促进喉癌细胞死亡并抑制其侵袭的机制研究[J]. 中国临床药理学与治疗学, 2023, 28(11): 1209-1218.